Understanding the genetic driver behind tumorigenesis is critical for the development of cancer therapeutics. Scientists at Crown Bioscience have deployed the latest genomic characterization technologies to understand the genetic background of our cancer cell line and HuPrimeÒ models, thus providing the comprehensive genetic context for our clients to understand their compounds.
Our HuBaseÒ offers intuitive navigation control and live-searchable function to enable cancer researchers to analyze hundreds of cancer cell lines and tumor models in:
- Clinical information
- Diagnosis and pathology
- Whole genome gene expression profiling
- Whole genome copy number variation
- Hot spot sequence mutation
- Key biomarker IHC information
- Tumor growth and standard-of-care response curve